  Cardiac in silico clinical trials can virtually assess the safety and
efficacy of therapies using human-based modelling and simulation. These
technologies can provide mechanistic explanations for clinically observed
pathological behaviour. Designing virtual cohorts for in silico trials requires
exploiting clinical data to capture the physiological variability in the human
population. The clinical characterisation of ventricular activation and the
Purkinje network is challenging, especially non-invasively. Our study aims to
present a novel digital twinning pipeline that can efficiently generate and
integrate Purkinje networks into human multiscale biventricular models based on
subject-specific clinical 12-lead electrocardiogram and magnetic resonance
recordings. Essential novel features of the pipeline are the human-based
Purkinje network generation method, personalisation considering ECG R wave
progression as well as QRS morphology, and translation from reduced-order
Eikonal models to equivalent biophysically-detailed monodomain ones. We
demonstrate ECG simulations in line with clinical data with clinical
image-based multiscale models with Purkinje in four control subjects and two
hypertrophic cardiomyopathy patients (simulated and clinical QRS complexes with
Pearson's correlation coefficients > 0.7). Our methods also considered possible
differences in the density of Purkinje myocardial junctions in the
Eikonal-based inference as regional conduction velocities. These differences
translated into regional coupling effects between Purkinje and myocardial
models in the monodomain formulation. In summary, we demonstrate a digital twin
pipeline enabling simulations yielding clinically-consistent ECGs with clinical
CMR image-based biventricular multiscale models, including personalised
Purkinje in healthy and cardiac disease conditions.
